Medacta Group (XSWX:MOVE) Debt-to-Equity : 0.61 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Medacta Group Debt-to-Equity?

Medacta Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF51.9 Mil. Medacta Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF138.6 Mil. Medacta Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was CHF311.3 Mil. Medacta Group's debt to equity for the quarter that ended in Dec. 2023 was 0.61.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Medacta Group's Debt-to-Equity or its related term are showing as below:

XSWX:MOVE' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.28 Med: 0.62 Max: 1.83
Current: 0.61

During the past 9 years, the highest Debt-to-Equity Ratio of Medacta Group was 1.83. The lowest was 0.28. And the median was 0.62.

XSWX:MOVE's Debt-to-Equity is ranked worse than
77.72% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs XSWX:MOVE: 0.61

Medacta Group Debt-to-Equity Historical Data

The historical data trend for Medacta Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group Debt-to-Equity Chart

Medacta Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.24

0.91

0.59

0.62

0.61

Medacta Group Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial									0.59	0.09	0.62	0.13	0.61

Competitive Comparison of Medacta Group's Debt-to-Equity

For the Medical Devices subindustry, Medacta Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medacta Group's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Medacta Group's Debt-to-Equity falls into.

Medacta Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Medacta Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(51.901	+	138.58)	/	311.251
	=	0.61

Medacta Group's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(51.901	+	138.58)	/	311.251
	=	0.61

Medacta Group (XSWX:MOVE) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Medacta Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Medacta Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medacta Group (XSWX:MOVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (XSWX:MOVE) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

MOVEz:UK

Address

Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874

Website

https://www.medacta.com

Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. The company offers solutions for Hip, Knee, Shoulder and Spine.